rates adjusted for age, sex, infection subclass, and type of antibiotic treatment used) by British Medical Journal Publishing Group

Similar documents
Summary of the latest data on antibiotic consumption in the European Union

Summary of the latest data on antibiotic consumption in the European Union

Cork and Kerry SARI Newsletter; Vol. 2 (2), December 2006

What is the problem? Latest data on antibiotic resistance

AMR epidemiological situation: ECDC update

Prof. Otto Cars. We are overconsuming a global resource. It is a collective responsibility by governments, supranational organisatons

Antimicrobial resistance (EARS-Net)

Antibiotic resistance: the rise of the superbugs

Quelle politique antibiotique pour l Europe? Dominique L. Monnet

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

A web-based interactive tool to explore antibiotic resistance and consumption via maps and charts

Consumption of antibiotics in hospitals. Antimicrobial stewardship.

HSE - Health Protection Surveillance Centre Surveillance of Antimicrobial Consumption in Ireland

The challenge of growing resistance

The evolutionary epidemiology of antibiotic resistance evolution

MRSA in the United Kingdom status quo and future developments

Antimicrobial resistance and antimicrobial consumption in Europe

Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel:

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Halting Infections in Long Term Care

WHO global and regional activities on AMR and collaboration with partner organisations

Prevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices

European poultry industry trends

Pneumococcus: Antibiotic Resistance in the Region

Antimicrobial consumption and resistance in humans in the EU and conclusions from the ECDC-EFSA- EMA JIACRA report

EU Health Priorities. Jurate Svarcaite Secretary General PGEU

Stop overuse of antibiotics in humans rational use

Summary of the latest data on antibiotic resistance in the European Union

WHO laboratory-based global survey on multidrug-resistant organisms (MDROs) in health care interim analysis

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient

Antimicrobial consumption

How do people obtain antibiotics in European countries: an overview

RCH antibiotic susceptibility data

Antimicrobial Stewardship in Continuing Care. Urinary Tract Infections Clinical Checklist

Special Eurobarometer 478. Summary. Antimicrobial Resistance

An Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings?

European Medicines Agency role and experience on antimicrobial resistance

CONTAGIOUS COMMENTS Department of Epidemiology

Antibiotic Stewardship Program (ASP) CHRISTUS SETX

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases

How is Ireland performing on antibiotic prescribing?

TECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017

THE DEVELOPMENT OF A RISK BASED MEAT INSPECTION SYSTEM SANCO / 4403 / 2000

Antimicrobial Susceptibility Patterns

A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya

Antimicrobial consumption

Antibiotic Resistance in the European Union Associated with Therapeutic use of Veterinary Medicines

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

Cipro for gram positive cocci in urine

by author ESCMID Online Lecture Library EUCAST The European Committee on Antimicrobial Susceptibility Testing September 2010

«Antibiotic Stewardship» programmes & antibiotic resistance

Cephalosporins, Quinolones and Co-amoxiclav Prescribing Audit

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1

REPORT ON POINT PREVALENCE SURVEY OF ANTIMICROBIAL PRESCRIPTION IN EUROPEAN NURSING HOMES, November 2009

18/08/2016. Safe Patient Care. Keeping our Residents Safe. Background. Infection Prevention and Control developing over the last 40 years

Antimicrobial Resistance. Tackling the Burden in the European Union. Briefing note for EU/EEA countries

QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)

This document is available on the English-language website of the Banque de France

EssayOnDeclawingCatsForStudents

Key words: Urinary tract infection, Antibiotic resistance, E.coli.

An agency of the European Union

Foodborne Zoonotic Parasites

Surveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe

Chart showing the average height of males and females in various world countries.

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

Special Eurobarometer 445. Summary

Carbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S

The threat of multidrug-resistant microorganisms and how to deal with it in Europe

Prevention & Management of Infection post Trans Rectal Ultrasound (TRUS) biopsy

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Cipro for klebsiella uti

Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly

Gram negative bacteraemia

CONTAGIOUS COMMENTS Department of Epidemiology

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

EARS Net Report, Quarter

Urinary Tract Infection Workshop

GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS

Import Restrictions for Passengers

Hosted by the Infection Prevention Society A Webber Training Teleclass

Antimicrobial Cycling. Donald E Low University of Toronto

Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector

Concise Antibiogram Toolkit Background

Infection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention

RULES & REGULATIONS EUKANUBA WORLD CHALLENGE 2019 Birmingham March 7th

ESCMID Online Lecture Library. by author

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

ake National Point Prevalence Survey of Healthcare Associated Infections, Device usage and Antimicrobial use in Long-Term Care Facilities 2017 HALT-3

Salmonella monitoring data, food-borne outbreaks and antimicrobial resistance data for 2014 in the European Union

Punto di vista dell EFSA e raccolta dati Valentina Rizzi Unit on Biological Monitoring (BIOMO)

Antibacterial Resistance in Wales

TITLE: NICU Late-Onset Sepsis Antibiotic Practice Guideline

Antimicrobial Susceptibility Testing: Advanced Course

Food & Veterinary Office

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

OECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH. Michele Cecchini OECD Health Division

9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS

EFSA s activities on Antimicrobial resistance in the food chain. Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA

ANTIMICROBIAL STEWARDSHIP

Transcription:

Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis Craig J Currie BMJ 2014;349:g5493 23 September 2014 More than one in 10 initial antibiotic monotherapies for upper and lower respiratory tract skin and soft tissue infections were associated with failure over a 22 year period in UK primary care Overall antibiotic treatment failure rates increased from 1991 to 2012 by more than 10%, Treatment failure rates increased in some notable cases, especially when the antibiotic selected was not considered first choice for the indications studied

Fig 2 Consultation rates for selected infection classes, proportion of infections in selected classes treated with antibiotic, rate of antibiotic treatment failure by infection class, and fully adjusted d and indexed d treatment t t failure rates (indexed d to 1991=100, 100 antibiotic treatment t t failure rates adjusted for age, sex, infection subclass, and type of antibiotic treatment used). Currie C J et al. BMJ 2014;349:bmj.g5493 2014 by British Medical Journal Publishing Group

We use a lot of antibiotics in Ireland Antibiotic use is mid to high hcompared with other EU countries 50 40 30 itants per Day 20 10 0 Def fined Daily Dosess per 1000 Inhab (DID) Switzerland Romania Latvia Estonia Netherlands Russian Federation Sweden Slovenia Germany Norway Austria Denmark Hungary UK Finland Czech Republic Bulgaria Iceland Spain Lithuania Ireland Croatia Malta Israel Portugal Poland Slovakia Belgium Luxembourg Italy France Cyprus Greece 80% community consumption 2004 2005 2006 2007 2008 2009 Fig : Total outpatient antibiotic use in Europe 2004 to 2009 expressed in DDD per 1000 inhabitants per day. Data from the European Surveillance of Antimicrobial Consumption (ESAC) project. Data source: HPSC 3

MDR K. pneumonia

EARSS 2013 % MDR E. coli: 14.7% Commentary: Number and % ESBL-positive and MDR E. coli are the highest since surveillance began in 2002 ESBL-positive and MDR E. coli have been increasing since 2004 Invasive E. coli infections Number Invasive E. coli cases: 2,52626 Number ESBL-positive E. coli cases: 262 (of 2,510 tested) % ESBL-positive E. coli: 10.4% Number MDR E. coli cases: 370 (of 2,520 tested)

Proportion of bloodstream infections caused by resistant bacteria, 2004 to 2011 45% 40% Meticllin resistant Staph aureus (MRSA) Pro oportion resistanc ce 35% 30% 25% 20% 15% 10% Vancomycin resistant enterococcus (VRE) Quinolone resistant E coli Penicillin resistant Strep pneumoniae Erythromicin i resistant it ts pneumoniae 5% Multiple resistant E coli 0% Year Cephalosporin resistant E coli Data source: HPSC

C. Difficile 1992-20022002 Infoscan & CUH.

HALT 2013 Reasons & Sites for which Antimicrobials were Prescribed LTCF > 12 month 9% Urinary tract 14% Respiratory tract 43% Skin or Wound 34% Other 9.3%residents were on an antibiotic

HALT 2013 Breakdown of prophylaxis and treatment, by body site LTCF <12 month 11.2 % residents were on an antibiotic 14% 11% 20% 86% 34% 34% Urinary tract Respiratory tract Skin or Wound Other Prophylaxis 17% 83% Treatment

HALT 2013 Breakdown of prophylaxis and treatment, by body site> 12 month LTCF The vast majorityof of prophylaxis was for UTIprevention (76%). Treatment of RTI (45%) and UTI (25%) were the most frequent indications for therapeutic antimicrobials 4% 7% 13% 20% 10% 25% Urinary tract Respiratory tract 76% 45% Skin or Wound Other Prophylaxis Treatment 39% 61%

What were the most common HCAI types in the Ireland 2010 & 2011 HALT surveys?

Urinary Pathogens Infoscan 2001. 80 70 60 50 40 30 20 10 0 73 GP Hosp 8 10 4 3 coli prot strep staph pseud other

E. coli. Gram Negative Bacilli Coliforms or Enterobacteraciae. Klebsiella pneumoniae. Enterobacter. Acinetobacter spp. Serratia. Proteus. Pseudomonas. Also

Hospital UTI Resistance Rates % CUH 1992---2013. 80 70 60 50 40 30 20 10 0 65 56 53.7 Hosp 1992 Hosp 2001 2005/6 Hosp 2013 GP 2013 40 35.1 32 28 30.1 25 27 26.3 23 18.9 20 15 15 14 8.3 Amp Aug Cep Tri Nal Cip Nitro

CUH Urinary resistance rates 2013

CUH Urinary resistance rates 2013

National Guidelines UTI Symptoms and signs suggestive of urinary tract infection include: Dysuria Frequency Urgency New Onset Incontinence Fever >38 C Suprapubic Tenderness Haematuria

National Guidelines Uncomplicated UTI Trimethoprim 200mg BD Nitrofurantoin* 50-100mg QDS for 7 days (*Avoid in renal impairment) Or based on local resistance rates Cephalexin 500mg BD Co-amoxiclav 625mg TDS

CUH Urinary resistance rates 2013

Urinary Tract Infections. Mid stream urine. SAMPLES. Fresh less than 2 hours. Store in fridge. Boric Acid (>5mls).

Urinary Tract Infections. Significant bacteriuria. > 100,000 000 cfu per ml. pure culture. Low counts may be significant in supra pubic tap specimens

Urinary Tract Infections. Contamination. 10,000 000 to 1,000 +/- mixture of colonies.

Pyuria. Urinary Tract Infections. >15 white cells per cmm. Significant RBCS >7 per cmm. Epithelial cells---contamination.

Urinary Tract Infections. Pyuria & no growth. Antibiotics. Chlamydia/gonococci? myco TB. Glomerulonephritis. Urethral syndrome. Fastidious bacteria.

Urinary Tract Infections. Bacteruria and no pyuria. Contaminants. Significant in pregnant. Significant if abnormal renal tract.

Urine Culture and Microscopy Microscopy White blood cells >500 per cmm Red blood cells 30 per cmm Organisms + Culture Proteus mirabilis > 100,000 organisms per ml Amoxycillin S Ciprofloxacin s Augmentin S Nitrofurantoin R Cephalexin S Trimethoprim R

Urine Culture and Microscopy Urine Culture and Microscopy Technically Validated (Q) Microscopy White blood cells >500 per cmm Red blood cells 10 per cmm ^Organisms + Culture Escherichia coli > 100,000 organisms per ml Main organism in a mixed growth Amoxycillin R Ciprofloxacin r Augmentin S Nitrofurantoin S Cephalexin R Trimethoprim R

Urine Culture and Microscopy Microscopy White blood cells 40 per cmm Red blood cells 0 per cmm Organisms + Epithelial cells + Culture Mixed growth > 100,000000 organisms per ml

Urine Culture and Microscopy Microscopy White blood cells 10 per cmm Red blood cells 10 per cmm Yeasts + Culture Candida da sp. 0B > 100,000 organisms s per ml Main organism in a mixed growth

All patients 8 weeks period suspected UTI MSU sent for lab analysis Only 20 % positive Yet 56% received and antimicrobial Of those treated only 14% received the correct antibiotic for the bug grown in their urine. Huge variation in first line antibiotic only 38% followed guideline recommendation. Antimicrobial management and the appropriateness of treatment of urinary tract infection in General Practice in Ireland Akke Vellinga1*, Martin Cormican2,3, Belinda Hanahoe2, Kathleen Bennett4 and Andrew W Murphy1

Poor adherence to national guidelines Co-amoxyclav 33% Trimethoprim 26% Fluroquinolones 17% In this study high h local l resistance levels l to trimethoprim caution as first line but nitrofurantoin t i would have been appropriate for most positive urines, cheaper and less potential for developing resistance than ciproxin

KEY MESSAGES Residents in long term care facilities have high rates of abnormal dipstick and urine test results WITHOUT infection necessarily being present. Antibiotic therapy in these cases does not reduce mortality or prevent symptomatic episodes, rather it increases side effects and leads to antibiotic resistance. DO NOT ROUTINELY USE ANTIBIOTIC PROPHYLAXIS TO PREVENT URINARY TRACT INFECTION